Show Summary Details

Quick Reference

A cyclic lipopeptide antibiotic that is active against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate and -resistant S. aureus, and vancomycin-resistant Enterococcus faecalis and E. faecium (VRE). Acts by inhibiting lipoteichoic acid synthesis as a consequence of membrane binding in the presence of calcium.

Subjects: Clinical Pharmacology and Therapeutics.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.